A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...
In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...
For Patients With mCRPC, Results With Pluvicto in Real-World Settings Keep Pace With Clinical Trials
Real-world PRECISION data in 500 taxane-naïve, PSMA-positive mCRPC patients showed median PFS 13.5 months (95% CI, 11.7–14.7), aligning with PSMAfore efficacy expectations. Earlier sequencing mattered ...
Performance and Operational Feasibility of Epstein-Barr Virus–Based Screening for Detection of Nasopharyngeal Carcinoma: Direct Comparison of Two Alternative Approaches Activation of the androgen ...
This report is the first to examine the influence of inherited variation in the androgen metabolic pathway on the efficacy of ADT, establishing the importance of pharmacogenomics on individual's ...
Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.
Philadelphia, May 12, 2025 – New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in both hormone-sensitive and castration-resistant ...
Researchers from the Shanghai Institute of Biochemistry and Cell Biology of the Chinese Academy of Sciences and the Institute of Cancer Research in Shenzhen Bay Laboratory have identified the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results